Fingerprint

Dive into the research topics of 'Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study'. Together they form a unique fingerprint.

Medicine & Life Sciences